Amphastar Pharmaceuticals Inc (AMPH)
Cost of Revenue
$381.91M
TTM · Period ending: · USD
AMPH Cost of Revenue
Latest reported$381.91Mperiod ending
Latest reported$381.91Mperiod ending
AMPH TTM Cost of Revenue ($142.73M → $381.91M)
TTM cost of revenue
High-resolution chart · PNG
AMPH cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 381,911,000 | |
| 379,402,000 | |
| 363,830,000 | |
| 366,270,000 | |
| 359,954,000 | |
| 359,258,000 | |
| 358,527,000 | |
| 340,617,000 | |
| 325,892,000 | |
| 311,638,000 | |
| 293,274,000 | |
| 275,164,000 | |
| 264,630,000 | |
| 251,767,000 | |
| 250,127,000 | |
| 250,925,000 | |
| 250,321,000 | |
| 244,497,000 | |
| 238,029,000 | |
| 232,465,000 | |
| 218,373,000 | |
| 216,715,000 | |
| 206,506,000 | |
| 197,419,000 | |
| 195,381,000 | |
| 189,412,000 | |
| 190,434,000 | |
| 195,433,000 | |
| 196,831,000 | |
| 195,055,000 | |
| 187,500,000 | |
| 172,322,000 | |
| 163,314,000 | |
| 156,870,000 | |
| 149,380,000 | |
| 153,139,000 | |
| 152,475,000 | |
| 150,354,000 | |
| 150,976,000 | |
| 151,135,000 | |
| 160,814,000 | |
| 165,030,000 | |
| 174,172,000 | |
| 174,347,000 | |
| 175,977,000 | |
| 169,449,000 | |
| 159,205,000 | |
| 150,536,000 | |
| 141,654,000 | |
| 142,682,000 | |
| 142,726,000 | |
| 137,759,000 |